PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $991,117 | -23.2% | 32,305 | +0.3% | 0.93% | -19.2% |
| Q2 2023 | $1,290,054 | +0.7% | 32,195 | +2.5% | 1.16% | +0.1% |
| Q1 2023 | $1,281,434 | +28.3% | 31,400 | +21.4% | 1.15% | +27.4% |
| Q4 2022 | $998,455 | -26.1% | 25,860 | +1.7% | 0.91% | -31.6% |
| Q3 2022 | $1,352,000 | -5.6% | 25,420 | +3.5% | 1.32% | +1.8% |
| Q2 2022 | $1,432,000 | -24.0% | 24,565 | -0.5% | 1.30% | -9.8% |
| Q1 2022 | $1,884,000 | +26.8% | 24,690 | 0.0% | 1.44% | +32.3% |
| Q4 2021 | $1,486,000 | +12.0% | 24,690 | +4.2% | 1.09% | +4.4% |
| Q3 2021 | $1,327,000 | -6.7% | 23,690 | +1.0% | 1.04% | -4.3% |
| Q2 2021 | $1,423,000 | -15.0% | 23,450 | -1.9% | 1.09% | -20.9% |
| Q1 2021 | $1,675,000 | +10.9% | 23,895 | -5.3% | 1.38% | -5.3% |
| Q4 2020 | $1,510,000 | – | 25,240 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |